Takeda and Frazier Healthcare Partners announce collaboration to launch Phathom Pharma

Japan |  News | 0 Comment | 20 May, 2019

Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on the development and commercial...Read more

Takeda announces results of Phase 3b VARSITY studies

Japan |  News | 0 Comment | 20 May, 2019

Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, which demonstrated that the gut-selective biologic vedolizumab (Entyvi...Read more

Daiichi Sankyo fails to hold up influenza vaccine project

Japan |  News | 0 Comment | 20 May, 2019

Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build a scheme to supply vaccines for 40 million people in the time allott...Read more

Eisai to present data on oncology pipeline and products

Japan |  News | 0 Comment | 16 May, 2019

Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discovered lenvatinib mesylate (product name: Lenvima, "lenvatinib", kinase...Read more

Teijin and AMED to develop drugs for frail elders

Japan |  News | 0 Comment | 17 May, 2019

Teijin Limited has announced that it has signed a research and development agreement with the Japan Agency for Medical Research and Development (AMED) to form an industry-government-academi...Read more

Takeda's BLA for Vedolizumab gets approval by U.S. FDA

Japan |  News | 0 Comment | 14 May, 2019

Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for a subcutaneous (SC) for...Read more

Daiichi Sankyo launches hypertension drug in Japan

Japan |  News | 0 Comment | 15 May, 2019

Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: esaxerenone; hereafter, the drug). The drug is a novel, non-steroidal...Read more

Eisai to sell anti-rheumatic injection in Japan

Japan |  News | 0 Comment | 14 May, 2019

Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mbH (Medac) for the commercialization of its anti-rheumatic agent metho...Read more

Takeda sells surgical patch to Ethicon for $400M

Japan |  News | 0 Comment | 13 May, 2019

Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achieve safe, fast and reliable bleeding control, to Ethicon, a subsidiar...Read more

Novartis to acquire Xiidra in a $5.3B deal

Japan |  News | 0 Comment | 10 May, 2019

Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® (lifitegrast ophthalmic solution) ...Read more

Promethera Biosciences makes progress in HepaStem development programme

Japan |  News | 0 Comment | 09 May, 2019

Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a first patient in a Phase 2a clinical study for the company’s He...Read more

Promethera Biosciences completes €39.7 M Series D Financing

Japan |  News | 0 Comment | 08 May, 2019

Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a €39.7 million (JPY4.94 billion) Series D financing. The round...Read more

Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response

Japan |  News | 0 Comment | 08 May, 2019

Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal phase 2 DESTINY-Breast01 trial of [fam-] trastuzumab deruxtecan (DS-...Read more

Eisai with UK DRI launches new Post-Doctoral programme

Japan |  News | 0 Comment | 08 May, 2019

Eisai Co., Ltd. and the UK Dementia Research Institute (UK DRI) announced the launch of a joint post-doctoral programme to support the advancement of novel dementia research. This first-of-...Read more

Takeda collaborates with Skyhawk to develop solutions for neurodegenerative diseases

Japan |  News | 0 Comment | 07 May, 2019

US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutical Company Limited in which Skyhawk will use its SkySTAR™techno...Read more

Takeda opens new global research center in San Diego

Japan |  News | 0 Comment | 03 May, 2019

Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year presence in San Diego, the 165,000-square-foot facility is home to mor...Read more

Takeda announces Andrey Potapov as ICMEA Area Head

Japan |  News | 0 Comment | 30 Apr, 2019

Global biopharmaceutical company Takeda announced Andrey Potapov as its Area Head for India, CIS (the Commonwealth of Independent States), the Middle East including Turkey, and Africa (ICME...Read more

Japanese scientists reveal potential of technology to detect cancer

Japan |  News | 0 Comment | 29 Apr, 2019

Researchers at Okayama University in Japan have reported in the journal Sensors and Actuators B: Chemical that terahertz radiation can be used to rapidly detect makers for breast-cancer cel...Read more